Tech Company Financing Transactions

Velicept Therapeutics Funding Round

Velicept Therapeutics, based in Wayne, raised $21 million from CAM Capital, Longitude Capital Management and private investors.

Transaction Overview

Announced On
12/3/2015
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series B
Investors

CAM Capital (Lead Investor)

Longitude Capital Management (Lead Investor)

Proceeds Purpose
Velicept Therapeutic Inc. of Malvern, Pa., plans to use the proceeds from the series B financing -- led by CAM Capital and Longitude Capital -- to advance mid-stage stage testing of solabegron, its lead new drug candidate.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
640 Lee Rd. 119
Wayne, PA 19087
USA
Email Address
Not Recorded
Overview
Velicept Therapeutics, Inc. is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs. Its lead program, solabegron, is a highly differentiated novel compound being investigated for overactive bladder (OAB) and irritable bowel syndrome (IBS).
Profile
Velicept Therapeutics LinkedIn Company Profile
Social Media
Velicept Therapeutics Company Twitter Account
Company News
Velicept Therapeutics News
Facebook
Velicept Therapeutics on Facebook
YouTube
Velicept Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
James Walker
  James Walker LinkedIn Profile  James Walker Twitter Account  James Walker News  James Walker on Facebook
Chief Financial Officer
Douglas Gessl
  Douglas Gessl LinkedIn Profile  Douglas Gessl Twitter Account  Douglas Gessl News  Douglas Gessl on Facebook
Chief Medical Officer
Clarence Young
  Clarence Young LinkedIn Profile  Clarence Young Twitter Account  Clarence Young News  Clarence Young on Facebook
Chief Scientific Officer
Eliot Ohlstein
  Eliot Ohlstein LinkedIn Profile  Eliot Ohlstein Twitter Account  Eliot Ohlstein News  Eliot Ohlstein on Facebook
VP - Operations
Ray Stevens
  Ray Stevens LinkedIn Profile  Ray Stevens Twitter Account  Ray Stevens News  Ray Stevens on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/3/2015: Kesios Therapeutics venture capital transaction
Next: 12/3/2015: OpsClarity venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary